Reportedly, chronic inflammation can accelerate disease progression by promoting immune suppression, inhibiting the function of tumor suppressors, and activating tumor-associated signaling pathways such as the NF-κB pathway, particularly within the BMME [8, 9]. This evidence concerns the gene NFKB1 and neoplasm.